UCL Institute of Neurology


Neurorehabilitation Group

(a) Sagittal PD (b) spinal cord at baseline, (c) 1-year follow-up reduction in SC-CSA in subject with PPMS*

Retraining the brain to regain functional movement and cognitive processes after neurological damage and to compensate for loss.


Professor Alan Thompson FMedSci, FRCP, FRCPI

Collaborative Group:

Research Goals

  • To understand the mechanisms of disability and recovery, particularly in progressive neurological disorders.
  • To evaluate the effectiveness of neurorehabilitation and the use of outcome measures.
  • To assess and improve symptomatic management of neurological disorders.
  • To develop collaborations between allied health professionals, recognizing the multi-faceted needs of the patient along the neurorehabilitative pathway.

Funded Research Projects

  • Imaging research to facilitate new treatments for multiple sclerosis. Funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland
  • ‘Sustainable Reporters’, empowering the MS patient community by creating dialogue with leading experts in MS. Funded by the Wellcome Trust
  • External insults to the nervous system. Funded by the German Aerospace Center for Health Research – ERA-NET NEURON
Recent publications from Neurorehabilitation

Further information

* Cawley et al. (2017). Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis. Mult Scler. 2017 May 1:1352458517709954. doi: 10.1177/1352458517709954.